Skip to main content

. 1979 Apr;7(4):410–412. doi: 10.1111/j.1365-2125.1979.tb00957.x

Plasma salicylate levels after soluble and effervescent aspirin.

D Orton, R Treharne Jones, T Kaspi, R Richardson

PMCID: PMC1429652 PMID: 444362

410

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

LEONARDS J. R. The influence of solubility on the rate of gastrointestinal absorption of aspirin. Clin Pharmacol Ther. 1963 Jul-Aug;4:476–479. doi: 10.1002/cpt196344476. [DOI] [PubMed] [Google Scholar]
LIEBERMAN S. V., KRAUS S. R., MURRAY J., WOOD J. H. ASPIRIN FORMULATION AND ABSORPTION RATE. I. CRITERIA FOR SERUM MEASUREMENTS WITH HUMAN PANELS. J Pharm Sci. 1964 Dec;53:1486–1491. doi: 10.1002/jps.2600531211. [DOI] [PubMed] [Google Scholar]
Leonards J. R., Levy G. Reduction or prevention of aspirin-induced occult gastrointestinal blood loss in man. Clin Pharmacol Ther. 1969 Jul-Aug;10(4):571–575. doi: 10.1002/cpt1969104571. [DOI] [PubMed] [Google Scholar]
Volans G. N. Absorption of effervescent aspirin during migraine. Br Med J. 1974 Nov 2;4(5939):265–268. doi: 10.1136/bmj.4.5939.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
Volans G. N. The effect of metoclopramide on the absorption of effervescent aspirin in migraine. Br J Clin Pharmacol. 1975 Feb;2(1):57–63. doi: 10.1111/j.1365-2125.1975.tb00472.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES